Person · CIK 2065816

Mark Earl Hensley

Chief Operating Officer at Heron Therapeutics

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$0
Noticed on Form 144$0
Bought on Form 4$0
Companies1

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
Heron Therapeutics HRTXCommon StockDirectly179,322Oct 30, 2026 · Filing · EDGAR
Heron Therapeutics HRTXRestricted Stock Units
into Common Stock
Directly153,006Oct 30, 2026 · Filing · EDGAR

Sold and noticed by quarter

No sales or Form 144 notices with a stated value.

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Heron Therapeutics HRTX Chief Operating Officer · filings 2025 to 2026

DateTransactionSharesPriceValueHeld afterSource
Oct 30, 2026Option or RSU exercised or converted+11,770182,671 directFiling · EDGAR
Oct 30, 2026Shares withheld for tax or exercise price−3,349$0.28$938179,322 directFiling · EDGAR
Oct 30, 2026Option or RSU exercised or converted
Restricted Stock Units
−11,770153,006 directFiling · EDGAR
Aug 6, 2026Option or RSU exercised or converted+31,250179,789 directFiling · EDGAR
Aug 6, 2026Shares withheld for tax or exercise price−8,888$0.50$4K170,901 directFiling · EDGAR
Aug 6, 2026Option or RSU exercised or converted
Restricted Stock Units
−31,250343,750 directFiling · EDGAR
Jul 31, 2026Option or RSU exercised or converted+11,769148,539 directFiling · EDGAR
Jul 31, 2026Option or RSU exercised or converted
Restricted Stock Units
−11,769164,776 directFiling · EDGAR
May 6, 2026Option or RSU exercised or converted+125,000136,770 directFiling · EDGAR
May 6, 2026Option or RSU exercised or converted
Restricted Stock Units
−125,000375,000 directFiling · EDGAR
Apr 30, 2026Option or RSU exercised or converted+11,77011,770 directFiling · EDGAR
Apr 30, 2026Option or RSU exercised or converted
Restricted Stock Units
−11,770176,545 directFiling · EDGAR
Jan 30, 2026Grant or award from the company
Restricted Stock Units
+188,315188,315 directFiling · EDGAR
Jan 30, 2026Grant or award from the company
Performance Stock Units
+188,314188,314 directFiling · EDGAR
May 6, 2025Grant or award from the company
Restricted Stock Units
+500,000500,000 directFiling · EDGAR
All 9 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Nov 3, 2026Form 4Heron Therapeutics HRTXFiling · EDGAR
Aug 10, 2026Form 4Heron Therapeutics HRTXFiling · EDGAR
Aug 3, 2026Form 4Heron Therapeutics HRTXFiling · EDGAR
May 7, 2026Form 4Heron Therapeutics HRTXFiling · EDGAR
May 4, 2026Form 4Heron Therapeutics HRTXFiling · EDGAR
Feb 3, 2026Form 4Heron Therapeutics HRTXFiling · EDGAR
May 7, 2025Form 4Heron Therapeutics HRTXFiling · EDGAR
Apr 29, 2025Form 4Heron Therapeutics HRTXFiling · EDGAR
Apr 29, 2025Form 3Heron Therapeutics HRTXFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.